Cargando…

Sustained prothrombotic changes in convalescent patients with COVID-19

Detalles Bibliográficos
Autores principales:	von Meijenfeldt, Fien A, Thålin, Charlotte, Lisman, Ton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219290/ https://www.ncbi.nlm.nih.gov/pubmed/34171275 http://dx.doi.org/10.1016/S2352-3026(21)00146-0

Ejemplares similares

Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020)

Elevated factor V activity and antigen levels in patients with Covid‐19 are related to disease severity and 30‐day mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020)

Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers
por: Lundström, Annika, et al.
Publicado: (2021)

Unravelling the Role of Neutrophil Extracellular Traps in Acute Liver Failure
por: von Meijenfeldt, Fien A., et al.
Publicado: (2022)

Prothrombotic phenotype in COVID-19 severe patients
por: Helms, Julie, et al.
Publicado: (2020)

In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
por: Blasi, Annabel, et al.
Publicado: (2020)

Commentary on “The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1”
por: von Meijenfeldt, Fien A.
Publicado: (2022)

Elevated Plasma Levels of Cell‐Free DNA During Liver Transplantation Are Associated With Activation of Coagulation
por: von Meijenfeldt, Fien A., et al.
Publicado: (2018)

Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis
por: van den Boom, Bente P., et al.
Publicado: (2021)

Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Convalescent plasma transfusion for pregnant patients with COVID-19
por: Mastroianni, Antonio, et al.
Publicado: (2021)

Late Treatment for COVID-19 With Convalescent Plasma
por: Senefeld, Jonathon W., et al.
Publicado: (2022)

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

Use of convalescent plasma in the treatment of COVID-19
por: Joyner, Michael J., et al.
Publicado: (2023)

Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
por: Rodionov, Roman N, et al.
Publicado: (2021)

Appropriate selection of convalescent plasma donors for COVID-19
por: Tedder, Richard S, et al.
Publicado: (2021)

Reply to ‘Use of convalescent plasma in the treatment of COVID-19’
por: Murakami, Naoka, et al.
Publicado: (2023)

Convalescents
Publicado: (1907)

COVID-19 Convalescent Plasma and Concomitant Therapies in PassITON
por: Casadevall, Arturo, et al.
Publicado: (2022)

Extracardiac Prothrombotic Effects of COVID-19
por: Kankaria, Rohan, et al.
Publicado: (2022)

Extracardiac Prothrombotic Effects of COVID-19
por: Kankaria, Rohan, et al.
Publicado: (2023)

Prothrombotic State in COVID-19: Myth or Reality?
por: Bauer, Philippe R.
Publicado: (2021)

Prothrombotic Phenotype in COVID-19: Focus on Platelets
por: Barale, Cristina, et al.
Publicado: (2021)

The underrecognized prothrombotic vascular disease of COVID‐19
por: Cohoon, Kevin P., et al.
Publicado: (2020)

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
por: Zuo, Yu, et al.
Publicado: (2020)

Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
por: Peng, Pai, et al.
Publicado: (2021)

Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19
por: Kaiser, Rainer, et al.
Publicado: (2021)

Prothrombotic immune thrombocytopenia after COVID-19 vaccination
por: Tiede, Andreas, et al.
Publicado: (2021)

Mechanisms and management of prothrombotic state in COVID-19 disease
por: Acherjee, Trishna, et al.
Publicado: (2021)

Editorial: Thrombotic Disorders, Prothrombotic Abnormalities and COVID-19
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Prothrombotic status in COVID‑19 with diabetes mellitus (Review)
por: Mitroi, Roxana Madalina, et al.
Publicado: (2023)

Convalescent plasma: A possible treatment of COVID-19 in India
por: Teixeira da Silva, Jaime A.
Publicado: (2020)

The fragility of humoral immunity as a physiological safety marker for healthcare workers to return after COVID-19 convalescence
por: Silva, Vânia Lúcia, et al.
Publicado: (2021)

COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
por: Niu, Alex, et al.
Publicado: (2020)

Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes()
por: Páramo, José A.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
por: Rössler, Annika, et al.
Publicado: (2022)

Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection
por: Lopez-Castaneda, Sandra, et al.
Publicado: (2021)

Thrombomodulin Resistance May be Involved in the Prothrombotic State of COVID-19
por: Montaño, Adrián, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6qht6o51pg0hh5736okdd98g2u